Ascendis Pharma
ISIN US04351P1012
|WKN A14M6X
Overview
Description
Ascendis Pharma A/S is a biopharmaceutical company, which engages in the development of drug candidates. It specializes on its TransCon technologies to create prodrugs that provide for the predictable and sustained release of an unmodified parent drug. The company was founded by Jan Moller Mikkelsen, Dirk Vetter, and Harald Rau in September 2006 and is headquartered in Hellerup, Denmark.
Healthcare Biopharmaceuticals System-Specific Biopharmaceuticals Denmark
Financials
Key metrics
| Market capitalisation, EUR | 7,980.90 m |
| EPS, EUR | -7.47 |
| P/B ratio | 73.17 |
| P/E ratio | - |
| Dividend yield | 0.00% |
Income statement (2023)
| Revenue, EUR | 266.72 m |
| Net income, EUR | -481.45 m |
| Profit margin | -180.51% |
What ETF is Ascendis Pharma in?
There are 6 ETFs which contain Ascendis Pharma. All of these ETFs are listed in the table below. The ETF with the largest weighting of Ascendis Pharma is the Harbor Health Care UCITS ETF Accumulating.
| ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
|---|---|---|---|---|---|---|---|---|
| Harbor Health Care UCITS ETF Accumulating | 9.48% | Equity World Health Care Innovation | 40 | 0.89% | 15 | -0.91% | A2PFPC | IE00BJQTJ848 |
| L&G Gerd Kommer Multifactor Equity UCITS ETF USD Distributing | 0.01% | Equity World Multi-Factor Strategy | 3,647 | 0.50% | 67 | +20.43% | WELT0B | IE000FPWSL69 |
| iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 0.72% | Equity United States Health Care Biotech | 213 | 0.35% | 31 | +10.23% | A2JDYM | IE00BDZVHG35 |
| L&G Gerd Kommer Multifactor Equity UCITS ETF USD Accumulating | 0.01% | Equity World Multi-Factor Strategy | 3,647 | 0.50% | 356 | +21.03% | WELT0A | IE0001UQQ933 |
| iShares Nasdaq US Biotechnology UCITS ETF | 0.72% | Equity United States Health Care Biotech | 213 | 0.35% | 439 | +7.30% | A2DWAW | IE00BYXG2H39 |
| Fidelity Sustainable Research Enhanced US Equity UCITS ETF Acc | 0.04% | Equity United States Social/Environmental | 201 | 0.20% | 599 | +34.62% | A2P0ZN | IE00BKSBGS44 |
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH. Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.